RecruitingNCT06759558
Zuranolone for depression after stroke
About this title
Read the official source — NCT06759558Medication studyAges 21–65United States
Understand this study
Who could participate?
Listed age limits: 21 years to 65 years.
What will I do during this study?
The protocol includes: Completing questionnaires. Providing blood samples.
- Listed locations
- DurhamSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: January 30, 2026
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 6
- Sponsor
- Duke University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 21 Years to 65 Years
- Official registry ID
- NCT06759558
- Official title
Show the full official title
Allopregnanolone (Zuranolone) in Post-stroke Depression
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Durham
Questions about this study
What will I need to do?
You will provide blood samples.
Who is behind this study?
The study sponsor is Duke University, a university.
Does this study involve medication?
Yes. The study involves medication, including Zuranolone.
Who can participate?
Listed age limits: 21 years to 65 years.
Is this study still recruiting?
The registry lists this study as recruiting.
